Development agreements require legal possession or effective enjoyment for capital gains transfer; permissive possession and deferred consideration de...
Prolonged sterilisation of development rights supports capital-gains treatment, while business-income disallowances cannot govern capital-gains comput...
Additional evidence in transfer pricing dispute leads to fresh examination, while tax deductions, TDS credit, fee and refund interest require verifica...
Category II AIF pass-through taxation preserves non-business income character; investment receipts cannot be reclassified without applying recognised ...
SC rejected the petition challenging the show cause notice under Section 124 of the Customs Act, 1962 regarding pharmaceutical raw materials export. The Court directed the DGFT to review the petitioner's representations and make an appropriate determination. The authority was instructed to proceed with adjudication after DGFT's decision. The court found the show cause notice process appeared procedurally valid, with no substantive response provided by the petitioner. The petition was disposed of, effectively allowing administrative reconsideration of the classification and export documentation.
SC rejected the petition challenging the show cause notice under Section 124 of the Customs Act, 1962 regarding pharmaceutical raw materials export. The Court directed the DGFT to review the petitioner's representations and make an appropriate determination. The authority was instructed to proceed with adjudication after DGFT's decision. The court found the show cause notice process appeared procedurally valid, with no substantive response provided by the petitioner. The petition was disposed of, effectively allowing administrative reconsideration of the classification and export documentation.
Note: It is a system-generated summary and is for quick reference only.